Analysts are saying that Novo Nordisk could hit $40.37 by 2030. Bullish on NVO? Invest in Novo Nordisk on SoFi with no commissions. If it’s your first time signing up for SoFi, you’ll receive up to $1,000 in stock when you first fund your account. Plus, get a 1% bonus if you transfer your investments and keep them there until December 31, 2025.

As the maker of Ozempic and Wegovy, Danish pharmaceutical giant Novo Nordisk (NVO) is a global leader in diabetes care and obesity treatment. Despite a challenging year where shares have lost more than half their value, the stock’s potential upside remains significant, buoyed by ongoing innovation and a strong product pipeline. Traders and investors closely watch NVO’s price action alongside macroeconomic factors that include tariffs affecting

See Full Page